Literature DB >> 22256579

[Anesthetic management for electroconvulsive therapy using rocuronium bromide and sugammadex sodium in a patient with suspected malignant syndrome].

Tsuyoshi Maeda1, Tatsuya Enomoto, Yoichiro Kamiyama, Eiichi Inada.   

Abstract

A 62-year-old woman was treated for schizophrenia for 40 years. When the symptoms had deteriorated and new medications had to be added, CPK rose and she malignant syndrome was suspected. The electroconvulsive therapy (ECT) was proposed because of no improvement of the symptoms. We employed rocuronium bromide instead of suxamethonium considering malignant syndrome. The maintenance of anesthesia was necessary, because the duration of rocuronium bromide is longer than that of suxamethonium chloride. Anesthesia was induced and maintained using target controlled infusion (TCI) of propofol. After ECT was performed, sugammadex sodium 4 mg . kg-1 was administered at 2 post-tetanic counts (PTC) and the patient could come out the operating room safely and speedy. ECT using rocuronium bromide and sugammadex sodium can be performed safely and speedily, when suxamethonium chloride cannot be used.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22256579

Source DB:  PubMed          Journal:  Masui        ISSN: 0021-4892


  1 in total

1.  Comparison of the target-controlled infusion and the manual infusion of propofol anesthesia during electroconvulsive therapy: an open-label randomized controlled trial.

Authors:  Meng-Ling Hsieh; Yen-Ting Lu; Chih-Chung Lin; Chin-Pang Lee
Journal:  BMC Psychiatry       Date:  2021-02-04       Impact factor: 3.630

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.